T. Rowe PE
Have been seeing a handful of investments from TROW in venture and growth-type companies. Does anyone have insight on TROW’s private investing arm — team size, typical background, comp, location (assuming just B-more), etc?
Have been seeing a handful of investments from TROW in venture and growth-type companies. Does anyone have insight on TROW’s private investing arm — team size, typical background, comp, location (assuming just B-more), etc?
+55 | Ex Apollo Associate Q&A (But I Actually Answer) | 97 | 19m | |
+39 | How to Model SaaS Projections for Interviews | 49 | 12h | |
+34 | [Technical doubt]: Cash sweep and mandatory amortization | 9 | 2s | |
+33 | Q&A - Anything about PE / MBA / Life | 43 | 2h | |
+23 | European Megafunds (based on PEI 2023) | 17 | 1d | |
+22 | Is internal reporting at most funds really so Excel & PPT heavy still? | 7 | 8h | |
+22 | Partners Group Long Term | 8 | 10h | |
+18 | Advent NYC Culture/WLB - 2024 update | 6 | 50m | |
+18 | How is your life in PE? | 10 | 1d | |
+17 | Moving from PE Fund accounting to top 3 rating agency | 5 | 2d |
Career Resources
Don't know specifics on team but you're right in that they pretty much do mega rounds of pre-IPO companies that need massive checks that most traditional VCs won't write (you'll see similar investments from time to time from the CPPIBs of the world)
TROW has done a lot of work to up its game in private investing. Right now it's just one guy, David DiPietro and a few members who help do the business side. No analysts yet, but looking probably for Baltimore. He has a ton of opportunity in his team to support the company's efforts in equities. Some of TROW's funds are able to write checks that far outsize what a VC firm could do, which is what makes it so interesting. Currently, the efforts have seen these investments be included in existing funds, rather than become their own funds.
TROW has had some major successes and failures with privates too and the team largely focuses on Biotech later stage investments. Some successes include Sweetgreen, with other failures like WeWork hurting the practice's reputation. When these investments were made Private Equity was not its own division, so this work was done by traditional long-only stock pickers. Hopefully, the new team will be smart about its investments.
Recusandae illo quae voluptatem rerum. Velit atque qui ea est vel doloremque odit.
Laboriosam rem commodi aut quaerat architecto incidunt ut. Illum nam aspernatur facilis. Qui dolores sit iure illo maxime libero. Et voluptas ea nihil rerum sunt. Voluptates debitis reiciendis sunt officiis deleniti sit eos.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...